Results 131 to 140 of about 5,801,283 (182)

Development and Validation of a PIVKA-II-Based Model for HCC Risk Stratification in Patients With HCV-Related Cirrhosis Successfully Treated With DAA. [PDF]

Aliment Pharmacol Ther
Caviglia GP, Fariselli P, D'Ambrosio R, Colombatto P, Degasperi E, Ricco G, Abate ML, Birolo G, Troshina G, Damone F, Coco B, Cavallone D, Perbellini R, Monico S, Saracco GM, Brunetto MR, Lampertico P, Ciancio A.   +17 more
europepmc   +1 more source

Application of CT-based radiomics combined with laboratory tests such as AFP and PIVKA-II in preoperative prediction of pathologic grade of hepatocellular carcinoma. [PDF]

BMC Med Imaging
Wu M, Yu H, Pang S, Liu A, Liu J.
europepmc   +1 more source

Identification of serum tsRNA-Thr-5-0015 and combined with AFP and PIVKA-II as novel biomarkers for hepatocellular carcinoma. [PDF]

Sci Rep
Jin K, Wu J, Yang J, Chen B, Xu J, Bao H, Zong W, Xie C, Chen L, Wang F.   +9 more
europepmc   +1 more source

Alpha-fetoprotein-to-PIVKA-II ratio as a potential biomarker for hepatocellular carcinoma differentiation, imaging characteristics, and patient survival. [PDF]

Transl Cancer Res
Dieu-Merci MN, Hu J, Fang X, Zhao R, Xie X, Pan W, Aayush T, Yin F, Xingyue H, Han D.   +9 more
europepmc   +1 more source

Correction: Guarneri et al. Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma. <i>Cancers</i> 2025, <i>17</i>, 167. [PDF]

Cancers (Basel)
Guarneri V, Loggi E, Ramacieri G, Serra C, Vukotic R, Vitale G, Scuteri A, Cursaro C, Margotti M, Galli S, Caracausi M, Brodosi L, Gabrielli F, Andreone P.   +13 more
europepmc   +1 more source

Tumor burden score combined with AFP and PIVKA-II (TAP score) to predict the prognosis of hepatocellular carcinoma patients after radical liver resection. [PDF]

Langenbecks Arch Surg
Qiu ZC, Wu YW, Dai JL, Qi WL, Chen CW, Xu YQ, Shen JY, Li C, Wen TF.   +8 more
europepmc   +1 more source

Abnormal prothrombin (PIVKA-II) and hepatocellular carcinoma.

Tropical gastroenterology : official journal of the Digestive Diseases Foundation, 1991
H, Okuda, T, Nakanish, M, Furukawa, H, Yamagata, H, Obata   +4 more
openaire   +1 more source

Clinical value of serum AFP and PIVKA-II for diagnosis, treatment and prognosis of hepatocellular carcinoma. [PDF]

J Clin Lab Anal
Jin Y, Xu A.
europepmc   +1 more source

Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patients. [PDF]

Oncologist
Wang M, Qian G, Xiao H, Liu X, Sun L, Chen Z, Lin K, Yao L, Li C, Gu L, Xu J, Sun X, Qiu W, Pawlik TM, Yee Lau W, Lv G, Shen F, Yang T.   +17 more
europepmc   +1 more source

Urgent Global Need for PIVKA-II and AFP-L3 Measurements for Surveillance and Management of Hepatocellular Carcinoma. [PDF]

Liver Cancer
Kudo M.
europepmc   +1 more source